# Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease

> **NCT05330390** · — · UNKNOWN · sponsor: **The Second Hospital of Shandong University** · enrollment: 50 (estimated)

## Conditions studied

- Epilepsy
- Diabetic Nephropathy

## Interventions

- **DRUG:** Levetiracetam

## Key facts

- **NCT ID:** NCT05330390
- **Lead sponsor:** The Second Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-04
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05330390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05330390, "Study on the Population Pharmacokinetics of Levetiracetam in Epileptic Patients With Diabetic Kidney Disease". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05330390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*